上海医药(601607.SH)：地高辛片通过仿制药一致性评价

智通财经04-08

智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海上药信谊药厂有限公司(简称“上药信谊”)的地高辛片收到国家药品监督管理局颁发的《药品补充申请批准通知书》(通知书编号：2026B01912)，该药品通过仿制药一致性评价。地高辛片适用于1、治疗成人轻度至中度心力衰竭。地高辛可增加左心室射血分数并改善心力衰竭症状，表现为提高运动能力和减少心力衰竭相关住院和急诊治疗，而对死亡率...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2625916959?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-08 16:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2625916959","market":"us","top_or_hot":-1,"title":"上海医药(601607.SH)：地高辛片通过仿制药一致性评价","media":"智通财经","content":"<div>\n<p>智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海上药信谊药厂有限公司(简称“上药信谊”)的地高辛片收到国家药品监督管理局颁发的《药品补充申请批准通知书》(通知书编号：2026B01912)，该药品通过仿制药一致性评价。地高辛片适用于1、治疗成人轻度至中度心力衰竭。地高辛可增加左心室射血分数并改善心力衰竭症状，表现为提高运动能力和减少心力衰竭相关住院和急诊治疗，而对死亡率...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1425942.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>上海医药(601607.SH)：地高辛片通过仿制药一致性评价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n上海医药(601607.SH)：地高辛片通过仿制药一致性评价\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-08 16:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1425942.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海上药信谊药厂有限公司(简称“上药信谊”)的地高辛片收到国家药品监督管理局颁发的《药品补充申请批准通知书》(通知书编号：2026B01912)，该药品通过仿制药一致性评价。地高辛片适用于1、治疗成人轻度至中度心力衰竭。地高辛可增加左心室射血分数并改善心力衰竭症状，表现为提高运动能力和减少心力衰竭相关住院和急诊治疗，而对死亡率...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1425942.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1425942.html","article_id":"2625916959","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2625916959","pubTimestamp":1775635449,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，上海医药 发布公告，近日，公司下属上海上药信谊药厂有限公司的地高辛片收到国家药品监督管理局颁发的《药品补充申请批准通知书》，该药品通过仿制药一致性评价。地高辛片适用于1、治疗成人轻度至中度心力衰竭。地高辛可增加左心室射血分数并改善心力衰竭症状，表现为提高运动能力和减少心力衰竭相关住院和急诊治疗，而对死亡率无影响。在可能的情况下，地高辛应与利尿剂和血管紧张素转换酶抑制剂联合使用。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"601607":"上海医药","BK0188":"融资融券","BK0183":"MSCI概念","BK0012":"证金概念","BK0175":"白马股","BK0196":"行业龙头","BK0187":"一线龙头","BK0020":"浦东新区","BK0184":"上海国资改革","BK0028":"国家队","BK0099":"上海本地重组","BK0097":"医药电商","BK1197":"保健护理产品经销商","BK0209":"零售","02607":"上海医药"},"translate_title":"Shanghai Pharmaceuticals (601607.SH): Digoxin tablets passed the consistency evaluation of generic drugs","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1.5,"02607":1.5},"content_text":"智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海上药信谊药厂有限公司(简称“上药信谊”)的地高辛片收到国家药品监督管理局颁发的《药品补充申请批准通知书》(通知书编号：2026B01912)，该药品通过仿制药一致性评价。地高辛片适用于1、治疗成人轻度至中度心力衰竭。地高辛可增加左心室射血分数并改善心力衰竭症状，表现为提高运动能力和减少心力衰竭相关住院和急诊治疗，而对死亡率无影响。在可能的情况下，地高辛应与利尿剂和血管紧张素转换酶(ACE)抑制剂联合使用。2、可增加心力衰竭儿童患者的心肌收缩力。3、用于控制伴有快速心室率的心房颤动、心房扑动患者的心室率及室上性心动过速。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2625916959","isCrawlerRequest":true}